Moreover, a clear association exists between the initial degree of tumor shrinkage and progression free and overall survival in ALK + lung cancer patients treated with TKIs [31] and colorectal cancer patients treated with cetuximab [32, 33]. The gene discussed is ALK; the disease is lung carcinoma.